InterCure Ltd

InterCure Ltd maintains a capital structure characterized by significant leverage relative to its equity base, with long-term debt of ILS 183.0 million against total equity of ILS 396.5 million, resulting in a debt-to-equity ratio of 0.46. The company holds ILS 46.5 million in cash and equivalents, which is insufficient to cover its total liabilities of ILS 294.0 million, leading to a negative net cash position. Liquidity is assessed as medium risk, supported by a current ratio of 1.48, indicating short-term assets exceed short-term liabilities but with limited buffer. The market capitalization stands at ILS 17.6 billion, implying a high valuation multiple relative to its book value, with a price-to-book ratio of 44.3.

Profitability metrics indicate the company is currently unprofitable, reporting a net income loss of ILS 35.7 million and an operating income loss of ILS 27.2 million. Return on equity is negative at -9.01%, and return on assets is negative at -5.17%, reflecting the inability to generate returns on its asset base of ILS 690.6 million. The enterprise value to EBITDA ratio is negative at -649.82, and the EV-to-revenue ratio is 65.52, suggesting the market is pricing in significant future growth potential or asset value not reflected in current earnings. Gross profit is positive at ILS 40.7 million, indicating that core operations generate some margin before operating expenses, but this is insufficient to cover overhead and interest costs.

Segment and geographic revenue data are not provided in the input, preventing an analysis of revenue concentration or regional exposure. The company's revenue of ILS 270.2 million is treated as a consolidated figure without breakdown by product line or geography.

Historical period data for revenue and net income trends are absent, limiting the ability to assess growth trajectory or consistency of performance over time. The current financial snapshot represents the latest normalized period, but without historical context, the direction of revenue growth or margin expansion cannot be determined from the provided data.

Risk assessment highlights medium liquidity risk and low dilution risk. A key flag is the negative net cash position after subtracting total debt, which increases financial vulnerability to interest rate changes or refinancing difficulties. The low dilution risk suggests that the company is not currently issuing significant new shares, as basic and diluted shares outstanding are identical at 59.2 million.

Recent filing, news, and transcript observations are not provided in the input data. Therefore, no specific recent events, management signals, or competitor context can be integrated into the narrative. The analysis relies solely on the static financial and classification data provided.